Skip to main content
Top
Published in: Breast Cancer Research 5/2004

Open Access 01-10-2004 | Research article

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression

Authors: Martin C Abba, Jeffrey A Drake, Kathleen A Hawkins, Yuhui Hu, Hongxia Sun, Cintia Notcovich, Sally Gaddis, Aysegul Sahin, Keith Baggerly, C Marcelo Aldaz

Published in: Breast Cancer Research | Issue 5/2004

Login to get access

Abstract

Introduction

Genomic and transcriptomic alterations affecting key cellular processes such us cell proliferation, differentiation and genomic stability are considered crucial for the development and progression of cancer. Most invasive breast carcinomas are known to derive from precursor in situ lesions. It is proposed that major global expression abnormalities occur in the transition from normal to premalignant stages and further progression to invasive stages. Serial analysis of gene expression (SAGE) was employed to generate a comprehensive global gene expression profile of the major changes occurring during breast cancer malignant evolution.

Methods

In the present study we combined various normal and tumor SAGE libraries available in the public domain with sets of breast cancer SAGE libraries recently generated and sequenced in our laboratory. A recently developed modified t test was used to detect the genes differentially expressed.

Results

We accumulated a total of approximately 1.7 million breast tissue-specific SAGE tags and monitored the behavior of more than 25,157 genes during early breast carcinogenesis. We detected 52 transcripts commonly deregulated across the board when comparing normal tissue with ductal carcinoma in situ, and 149 transcripts when comparing ductal carcinoma in situ with invasive ductal carcinoma (P < 0.01).

Conclusion

A major novelty of our study was the use of a statistical method that correctly accounts for the intra-SAGE and inter-SAGE library sources of variation. The most useful result of applying this modified t statistics beta binomial test is the identification of genes and gene families commonly deregulated across samples within each specific stage in the transition from normal to preinvasive and invasive stages of breast cancer development. Most of the gene expression abnormalities detected at the in situ stage were related to specific genes in charge of regulating the proper homeostasis between cell death and cell proliferation. The comparison of in situ lesions with fully invasive lesions, a much more heterogeneous group, clearly identified as the most importantly deregulated group of transcripts those encoding for various families of proteins in charge of extracellular matrix remodeling, invasion and cell motility functions.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Berardo MD, Allred DC, O'Connell P: Breast cancer. In Principles of Molecular Medicine. Edited by: Jameson JL. 1998, Totowa, NJ: Human Press, 625-632.CrossRef Berardo MD, Allred DC, O'Connell P: Breast cancer. In Principles of Molecular Medicine. Edited by: Jameson JL. 1998, Totowa, NJ: Human Press, 625-632.CrossRef
3.
go back to reference Ponten J, Holmberg L, Trichopoulos D, Kallioniemi O, Kvale G, Wallgren A: Biology and natural history of breast cancer. Int J Cancer. 1990, 5: 5-21.CrossRef Ponten J, Holmberg L, Trichopoulos D, Kallioniemi O, Kvale G, Wallgren A: Biology and natural history of breast cancer. Int J Cancer. 1990, 5: 5-21.CrossRef
4.
go back to reference Charpentier A, Aldaz CM: The molecular basis of breast carcinogenesis. In The Molecular Basis of Human Cancer. Edited by: Coleman WB, Tsongalis GJ. 2002, Totowa, NJ: Human Press, 347-363.CrossRef Charpentier A, Aldaz CM: The molecular basis of breast carcinogenesis. In The Molecular Basis of Human Cancer. Edited by: Coleman WB, Tsongalis GJ. 2002, Totowa, NJ: Human Press, 347-363.CrossRef
5.
go back to reference Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH: Reduced expression of the small leucine-rich proteoglycans, Lumican, and Decorin is associated with poor outcome in node-negative breast cancer. Clin Cancer Res. 2003, 9: 207-214.PubMed Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH: Reduced expression of the small leucine-rich proteoglycans, Lumican, and Decorin is associated with poor outcome in node-negative breast cancer. Clin Cancer Res. 2003, 9: 207-214.PubMed
6.
go back to reference Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science. 1995, 270: 484-487.CrossRefPubMed Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science. 1995, 270: 484-487.CrossRefPubMed
7.
go back to reference Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science. 1997, 276: 1268-1272. 10.1126/science.276.5316.1268.CrossRefPubMed Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science. 1997, 276: 1268-1272. 10.1126/science.276.5316.1268.CrossRefPubMed
8.
go back to reference Baggerly KA, Deng Li, Morris JS, Aldaz CM: Differential expression in Sage: accounting for normal between-library variation. Bioinformatics. 2003, 19: 1477-1483. 10.1093/bioinformatics/btg173.CrossRefPubMed Baggerly KA, Deng Li, Morris JS, Aldaz CM: Differential expression in Sage: accounting for normal between-library variation. Bioinformatics. 2003, 19: 1477-1483. 10.1093/bioinformatics/btg173.CrossRefPubMed
9.
go back to reference Kal AJ, van Zonneveld AJ, Benes V, vand den Berg M, Koerkamp MG, Albermann K, Strack N, Ruijter JM, Richter A, Dujon B, Ansorge W, Tabak HF: Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles form yeast grown on two different carbon sources. Mol Biol Cell. 1999, 10: 1859-1872.CrossRefPubMedPubMedCentral Kal AJ, van Zonneveld AJ, Benes V, vand den Berg M, Koerkamp MG, Albermann K, Strack N, Ruijter JM, Richter A, Dujon B, Ansorge W, Tabak HF: Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles form yeast grown on two different carbon sources. Mol Biol Cell. 1999, 10: 1859-1872.CrossRefPubMedPubMedCentral
10.
go back to reference Man MZ, Wang X, Wang Y: Power_Sage: comparing statistical test for SAGE experiments. Bioinformatics. 2000, 16: 953-959. 10.1093/bioinformatics/16.11.953.CrossRefPubMed Man MZ, Wang X, Wang Y: Power_Sage: comparing statistical test for SAGE experiments. Bioinformatics. 2000, 16: 953-959. 10.1093/bioinformatics/16.11.953.CrossRefPubMed
11.
go back to reference Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 1999, 59: 5464-5470.PubMed Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 1999, 59: 5464-5470.PubMed
12.
go back to reference Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K: A SAGE (Serial Analysis of Gene Expression) view of breast tumor progression. Cancer Res. 2001, 61: 5697-5702.PubMed Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K: A SAGE (Serial Analysis of Gene Expression) view of breast tumor progression. Cancer Res. 2001, 61: 5697-5702.PubMed
13.
go back to reference Leerkes MR, Caballero OL, Mackay A, Torloni H, O'Hare MJ, Simpson AJG, de Souza SJ: In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells. Genomics. 2002, 79: 257-265. 10.1006/geno.2002.6691.CrossRefPubMed Leerkes MR, Caballero OL, Mackay A, Torloni H, O'Hare MJ, Simpson AJG, de Souza SJ: In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells. Genomics. 2002, 79: 257-265. 10.1006/geno.2002.6691.CrossRefPubMed
14.
go back to reference Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richarson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K: Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003, 1: 362-375.PubMed Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richarson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K: Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003, 1: 362-375.PubMed
15.
go back to reference Trougakos IP, Gonos ES: Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol. 2002, 34: 1430-1448. 10.1016/S1357-2725(02)00041-9.CrossRefPubMed Trougakos IP, Gonos ES: Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol. 2002, 34: 1430-1448. 10.1016/S1357-2725(02)00041-9.CrossRefPubMed
16.
go back to reference Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, Liu F, Wang K, Zhang DC, Wang Y, Wu M, Qian XH: Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol. 2003, 9: 650-654.CrossRefPubMedPubMedCentral Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, Liu F, Wang K, Zhang DC, Wang Y, Wu M, Qian XH: Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol. 2003, 9: 650-654.CrossRefPubMedPubMedCentral
17.
go back to reference Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S: Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer. 2004, 108: 23-30. 10.1002/ijc.11496.CrossRefPubMed Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S: Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer. 2004, 108: 23-30. 10.1002/ijc.11496.CrossRefPubMed
18.
go back to reference Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK: Overexpression of Clusterin in human breast carcinoma. Am J Pathol. 2000, 157: 393-399.CrossRefPubMedPubMedCentral Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK: Overexpression of Clusterin in human breast carcinoma. Am J Pathol. 2000, 157: 393-399.CrossRefPubMedPubMedCentral
19.
go back to reference Zhang YF, Homer C, Edwards SJ, Hananeia L, Lasham A, Royds J, Sheard P, Braithwaite AW: Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene. 2003, 22: 2782-2794. 10.1038/sj.onc.1206357.CrossRefPubMed Zhang YF, Homer C, Edwards SJ, Hananeia L, Lasham A, Royds J, Sheard P, Braithwaite AW: Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene. 2003, 22: 2782-2794. 10.1038/sj.onc.1206357.CrossRefPubMed
20.
go back to reference Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z: Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Res Treat. 1998, 48: 165-174. 10.1023/A:1005942923757.CrossRefPubMed Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z: Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Res Treat. 1998, 48: 165-174. 10.1023/A:1005942923757.CrossRefPubMed
21.
go back to reference Liu J, Hadjokas N, Mosley B, Estrov Z, Spence MJ, Vestal RE: Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Cytokine. 1998, 10: 295-302. 10.1006/cyto.1997.0283.CrossRefPubMed Liu J, Hadjokas N, Mosley B, Estrov Z, Spence MJ, Vestal RE: Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Cytokine. 1998, 10: 295-302. 10.1006/cyto.1997.0283.CrossRefPubMed
22.
go back to reference Grant SL, Douglas AM, Goss GA, Begley CG: Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors. 2001, 19: 153-162.CrossRefPubMed Grant SL, Douglas AM, Goss GA, Begley CG: Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors. 2001, 19: 153-162.CrossRefPubMed
23.
go back to reference Tocchetti A, Confalonieri S, Scita G, Di Fiore PP, Betsholtz C: In silico analysis of EPS8 gene family: genomic organization, expression profile, and protein structure. Genomics. 2003, 81: 234-244. 10.1016/S0888-7543(03)00002-8.CrossRefPubMed Tocchetti A, Confalonieri S, Scita G, Di Fiore PP, Betsholtz C: In silico analysis of EPS8 gene family: genomic organization, expression profile, and protein structure. Genomics. 2003, 81: 234-244. 10.1016/S0888-7543(03)00002-8.CrossRefPubMed
24.
go back to reference Wilson PD, Geng L, Li X, Burrow CR: The PKD1 gene product, 'polycystin-1', is a tyrosine-phosphorylated protein that colocalizes with a2b1-integrin in focal clusters in adherent renal epithelia. Lab Invest. 1999, 79: 1311-1323.PubMed Wilson PD, Geng L, Li X, Burrow CR: The PKD1 gene product, 'polycystin-1', is a tyrosine-phosphorylated protein that colocalizes with a2b1-integrin in focal clusters in adherent renal epithelia. Lab Invest. 1999, 79: 1311-1323.PubMed
25.
go back to reference Boucher C, Sandford R: Autosomal dominant polycystic disease (ADPKD, MIM 17 PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet. 3900, 186: 2309-2318. Boucher C, Sandford R: Autosomal dominant polycystic disease (ADPKD, MIM 17 PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet. 3900, 186: 2309-2318.
26.
go back to reference Wada Y, Kubota H, Maeda M, Taniwaki M, Hattori M, Imamura S, Iwai K, Minato N: Mitogen-inducible SIPA1 is mapped to the conserved syntenic group of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomic. 1997, 39: 66-73. 10.1006/geno.1996.4464.CrossRef Wada Y, Kubota H, Maeda M, Taniwaki M, Hattori M, Imamura S, Iwai K, Minato N: Mitogen-inducible SIPA1 is mapped to the conserved syntenic group of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomic. 1997, 39: 66-73. 10.1006/geno.1996.4464.CrossRef
27.
go back to reference May MJ, Ghosh MS: Rel/NF-kB and IkB proteins: an overview. Cancer Biol. 1997, 8: 63-73. 10.1006/scbi.1997.0057.CrossRef May MJ, Ghosh MS: Rel/NF-kB and IkB proteins: an overview. Cancer Biol. 1997, 8: 63-73. 10.1006/scbi.1997.0057.CrossRef
28.
go back to reference Curran JE, Weinstein SR, Griffiths LR: Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett. 2002, 188: 103-107. 10.1016/S0304-3835(02)00460-3.CrossRefPubMed Curran JE, Weinstein SR, Griffiths LR: Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett. 2002, 188: 103-107. 10.1016/S0304-3835(02)00460-3.CrossRefPubMed
29.
go back to reference Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999, 18: 6910-6924. 10.1038/sj.onc.1203238.CrossRefPubMed Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999, 18: 6910-6924. 10.1038/sj.onc.1203238.CrossRefPubMed
30.
go back to reference Silverman N, Maniatis T: NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001, 15: 2321-2342. 10.1101/gad.909001.CrossRefPubMed Silverman N, Maniatis T: NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001, 15: 2321-2342. 10.1101/gad.909001.CrossRefPubMed
31.
go back to reference Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW: Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol. 1997, 17: 3629-3639.CrossRefPubMedPubMedCentral Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW: Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol. 1997, 17: 3629-3639.CrossRefPubMedPubMedCentral
32.
go back to reference Kim EJ, Suliman A, Lam A, Srivastava RK: Failure of BCL-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand. Int J Oncol. 2001, 18: 187-194.PubMed Kim EJ, Suliman A, Lam A, Srivastava RK: Failure of BCL-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand. Int J Oncol. 2001, 18: 187-194.PubMed
33.
go back to reference Singh TR, Shankar S, Chen X, Asim M, Srivastava RK: Synergistic interactions of chemotherapeutic drug and tumor necrosis factor related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinomas in vivo. Cancer Res. 2003, 63: 5390-5400.PubMed Singh TR, Shankar S, Chen X, Asim M, Srivastava RK: Synergistic interactions of chemotherapeutic drug and tumor necrosis factor related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinomas in vivo. Cancer Res. 2003, 63: 5390-5400.PubMed
34.
go back to reference Myokai F, Takashiba S, Lebo R, Amar S: A novel lipopolysaccharide-induce transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA. 1999, 96: 4518-4523. 10.1073/pnas.96.8.4518.CrossRefPubMedPubMedCentral Myokai F, Takashiba S, Lebo R, Amar S: A novel lipopolysaccharide-induce transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA. 1999, 96: 4518-4523. 10.1073/pnas.96.8.4518.CrossRefPubMedPubMedCentral
35.
go back to reference Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B: A model for p53-induced apoptosis. Nature. 1997, 389: 300-305. 10.1038/38525.CrossRefPubMed Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B: A model for p53-induced apoptosis. Nature. 1997, 389: 300-305. 10.1038/38525.CrossRefPubMed
36.
go back to reference Berditchevski F: Complex of tetraspanins with integrins: more than meets the eye. J Cell Science. 2001, 114: 4143-4151.PubMed Berditchevski F: Complex of tetraspanins with integrins: more than meets the eye. J Cell Science. 2001, 114: 4143-4151.PubMed
37.
go back to reference Chung JY, Park YC, Ye H, Wu H: All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci. 2002, 115: 679-688.PubMed Chung JY, Park YC, Ye H, Wu H: All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci. 2002, 115: 679-688.PubMed
38.
go back to reference Sax JK, El-Deiry WS: Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem. 2003, 278: 36435-36444. 10.1074/jbc.M303191200.CrossRefPubMed Sax JK, El-Deiry WS: Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem. 2003, 278: 36435-36444. 10.1074/jbc.M303191200.CrossRefPubMed
39.
go back to reference Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P: Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol. 1997, 150: 497-507.PubMedPubMedCentral Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P: Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol. 1997, 150: 497-507.PubMedPubMedCentral
40.
go back to reference Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcok T, Murphy LC, Roughley PJ, Watson PH: Lumican and decorin are differentially expressed in human breast carcinomas. J Pathol. 2000, 192: 313-320. 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.3.CO;2-2.CrossRefPubMed Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcok T, Murphy LC, Roughley PJ, Watson PH: Lumican and decorin are differentially expressed in human breast carcinomas. J Pathol. 2000, 192: 313-320. 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.3.CO;2-2.CrossRefPubMed
41.
go back to reference Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE: The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res. 2002, 62: 5351-5357.PubMed Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE: The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res. 2002, 62: 5351-5357.PubMed
42.
go back to reference Henriet P, Blavier L, Declerck YA: Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. Acta Pathol Microbiol Immuno Scandinavica. 1999, 107: 111-119.CrossRef Henriet P, Blavier L, Declerck YA: Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. Acta Pathol Microbiol Immuno Scandinavica. 1999, 107: 111-119.CrossRef
43.
go back to reference Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.CrossRefPubMed Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.CrossRefPubMed
44.
go back to reference Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000, 10: 415-433. 10.1006/scbi.2000.0379.CrossRefPubMed Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000, 10: 415-433. 10.1006/scbi.2000.0379.CrossRefPubMed
45.
go back to reference Jones JL, Glynn P, Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol. 1999, 189: 161-168. 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2.CrossRefPubMed Jones JL, Glynn P, Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol. 1999, 189: 161-168. 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2.CrossRefPubMed
47.
go back to reference Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH: SPARC regulates the expression of collagen type I and transforming growth factor-beta 1 in mesangial cells. J Biol Chem. 1999, 274: 32145-32152. 10.1074/jbc.274.45.32145.CrossRefPubMed Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH: SPARC regulates the expression of collagen type I and transforming growth factor-beta 1 in mesangial cells. J Biol Chem. 1999, 274: 32145-32152. 10.1074/jbc.274.45.32145.CrossRefPubMed
48.
go back to reference Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001, 61: 5168-5178.PubMed Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001, 61: 5168-5178.PubMed
49.
go back to reference Nelson PS, Plymate SR, Wang K, True LD, Ware JL, Gan L, Liu AY, Hood L: Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 1998, 58: 232-236.PubMed Nelson PS, Plymate SR, Wang K, True LD, Ware JL, Gan L, Liu AY, Hood L: Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 1998, 58: 232-236.PubMed
50.
go back to reference Isler SG, Schenk S, Bendik I, Schraml P, Novotna H, Moch H, Sauter G, Ludwig CU: Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol. 2001, 18: 521-526.PubMed Isler SG, Schenk S, Bendik I, Schraml P, Novotna H, Moch H, Sauter G, Ludwig CU: Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol. 2001, 18: 521-526.PubMed
51.
go back to reference Hambrock HO, Nitsche DP, Hansen U, Bruckner P, Paulsson M, Maurer P, Hartmann U: SC1/Hevin: an extracellular calcium-modulated protein that binds collagen I. J Biol Chem. 2003, 278: 11351-11358. 10.1074/jbc.M212291200.CrossRefPubMed Hambrock HO, Nitsche DP, Hansen U, Bruckner P, Paulsson M, Maurer P, Hartmann U: SC1/Hevin: an extracellular calcium-modulated protein that binds collagen I. J Biol Chem. 2003, 278: 11351-11358. 10.1074/jbc.M212291200.CrossRefPubMed
52.
go back to reference Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH, Murphy LC: Expression of lumican in human breast carcinoma. Cancer Res. 1998, 58: 1348-1352.PubMed Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH, Murphy LC: Expression of lumican in human breast carcinoma. Cancer Res. 1998, 58: 1348-1352.PubMed
53.
go back to reference Evanko SP, Angello JC, Wight TN: Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999, 19: 1004-1013.CrossRefPubMed Evanko SP, Angello JC, Wight TN: Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999, 19: 1004-1013.CrossRefPubMed
54.
go back to reference Ricciardelli C, Brooks JH, Suwiwata S, Sakko AJ, Mayne K, Raymond WA, Seshadri R, LeBaron RG, Horsfall DJ: Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res. 2002, 8: 1054-1060.PubMed Ricciardelli C, Brooks JH, Suwiwata S, Sakko AJ, Mayne K, Raymond WA, Seshadri R, LeBaron RG, Horsfall DJ: Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res. 2002, 8: 1054-1060.PubMed
55.
go back to reference Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K: Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrate. J Biol Chem. 1989, 264: 8012-8018.PubMed Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K: Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrate. J Biol Chem. 1989, 264: 8012-8018.PubMed
56.
go back to reference Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem. 1988, 57: 593-625. 10.1146/annurev.bi.57.070188.003113.CrossRefPubMed Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem. 1988, 57: 593-625. 10.1146/annurev.bi.57.070188.003113.CrossRefPubMed
57.
go back to reference Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P: Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999, 112: 4615-4625.PubMed Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P: Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999, 112: 4615-4625.PubMed
58.
go back to reference Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart J: Transactivation of vimentin by B-catenin in human breast cancer cells. Cancer Res. 2003, 63: 2658-2664.PubMed Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart J: Transactivation of vimentin by B-catenin in human breast cancer cells. Cancer Res. 2003, 63: 2658-2664.PubMed
59.
go back to reference Hendrix MJ, Seftor EA, Seftor RE, Trevor KT: Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol. 1997, 150: 483-495.PubMedPubMedCentral Hendrix MJ, Seftor EA, Seftor RE, Trevor KT: Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol. 1997, 150: 483-495.PubMedPubMedCentral
Metadata
Title
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression
Authors
Martin C Abba
Jeffrey A Drake
Kathleen A Hawkins
Yuhui Hu
Hongxia Sun
Cintia Notcovich
Sally Gaddis
Aysegul Sahin
Keith Baggerly
C Marcelo Aldaz
Publication date
01-10-2004
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2004
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr899

Other articles of this Issue 5/2004

Breast Cancer Research 5/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine